U.S. markets open in 7 hours 55 minutes
  • S&P Futures

    4,260.25
    +4.25 (+0.10%)
     
  • Dow Futures

    34,203.00
    +121.00 (+0.36%)
     
  • Nasdaq Futures

    14,359.00
    +4.75 (+0.03%)
     
  • Russell 2000 Futures

    2,334.20
    +3.00 (+0.13%)
     
  • Crude Oil

    73.30
    0.00 (0.00%)
     
  • Gold

    1,776.50
    -0.20 (-0.01%)
     
  • Silver

    26.08
    +0.03 (+0.13%)
     
  • EUR/USD

    1.1943
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    15.97
    -0.35 (-2.14%)
     
  • GBP/USD

    1.3925
    +0.0004 (+0.03%)
     
  • USD/JPY

    110.8100
    -0.0250 (-0.02%)
     
  • BTC-USD

    34,514.39
    +1,752.24 (+5.35%)
     
  • CMC Crypto 200

    831.61
    +44.99 (+5.72%)
     
  • FTSE 100

    7,109.97
    +35.91 (+0.51%)
     
  • Nikkei 225

    29,068.85
    +193.62 (+0.67%)
     

SOS, GOEV & KDMN Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 12, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

SOS Limited (NYSE:SOS)
Class Period:
July 22, 2020 - February 25, 2021
Deadline: May 31, 2021
For more info: www.bgandg.com/sos

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (2) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (3) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

Canoo Inc.(NASDAQ:GOEV)
Class Period:
August 18, 2020 - March 29, 2021
Deadline: June 1, 2021
For more info: www.bgandg.com/goev

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) Canoo had decreased its focus on its plan to sell vehicles to consumers through a subscription model; (2) Canoo would de-emphasize its engineering services business; (3) contrary to prior statements, Canoo did not have partnerships with original equipment manufacturers and no longer engaged in the previously announced partnership with Hyundai; and (4) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Kadmon Holdings, Inc. (NASDAQ:KDMN)
Class Period:
October 1, 2020 - March 10, 2021
Deadline: June 2, 2021
For more info: www.bgandg.com/kdmn

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) the Belumosudil NDA was incomplete and/or deficient; (2) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (3) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (4) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/645939/SOS-GOEV-KDMN-Reminders-Bronstein-Gewirtz-Grossman-LLC-Reminds-Investors-of-Class-Actions-and-Upcoming-Lead-Plaintiff-Deadlines